Research and Development of Innovative Electrotherapy Medical Devices

Posted by:

While it is certainly true that modern medicine is more or less able to treat some of the diseases that were previously thought to be incurable, it is also true that ever more complex chemical compounds used in modern pharmacology often cause unpredictable side-effects, which sometimes lead to development of secondary diseases. Traditional (or what is sometimes called “alternative”) pharmacopeia offers solutions which can be less detrimental. However, taken out of the context of the entire traditional natural healing methodology, these medicinal compounds are often less effective and could cause detrimental side-effects of their own.

One possible alternative for afore mentioned problems, is the use of modern and innovative electrotherapeutic medical devices. When implemented properly, use of various types of electrical currents, magnetic, electric and electromagnetic fields, allows for direct modification of cellular metabolism of both prokaryotes and eukaryotic cells. Additionally, problems with varying rate of absorption into various tissues inherent in both modern and traditional pharmacopeia based therapies are largely, although not entirely, overcome by using tissue-penetrating EM fields. Surely, it is quite possible to cause cellular damage if some basic rules are not observed but when implemented correctly new approach to medical therapies is indeed possible.

Majority of conventional electrotherapies used in modern medicine, mostly in the area of physical rehabilitation, are basically some kind of derivation of galvanic current therapy, TENS stimulation or low strength oscillating magnetic field. Such devices are used almost exclusively in the treatment of pain, muscular stimulation and facilitation of bone healing processes. Overall effectiveness of such electrotherapy treatments is limited because they are not capable of addressing underlying medical conditions that caused symptoms in the first place, but are primarily used for treatment of symptoms. What is more, they are, for the most part, incapable of directly inducing significant bioactive effects such as cellular metabolism modification and rejuvenation, eradication of pathogens, induction of programmed apoptosis of neoplastic cells or direct modification of body’s pH.

On the other hand there are a number of historical electrotherapeutic technologies like Rife plasma antenna radiator devices and Multiple-Wave Oscillator (MWO) which are capable of achieving some of the aforementioned bioactive effects but which are also rather specialised in their function.

My Work on Innovative Electrotherapy Devices

I started experimenting with Rife type of technologies back in 2000. It took me nearly two and half years to produce first device capable of generating appropriate high-frequency signal, modulating it and mixing it, in a way that allowed me to experiment with much more complex waveforms. I also started experimenting with pulsed magnetic field (PMF) devices in order to determine if some common denominators exist, making them more (or less) efficient for the purpose of “in vivo” medical treatments.  It took me another five years before I managed to “connect the dots” and until I realised that there are indeed some common factors responsible for induced bioactive effects I observed during my experimentation with different technologies.

At that point I started considering what would be the best way to use practically gained knowledge in order to produce new types of electromedical devices, which would be capable of treating some of the medical conditions and diseases, which are otherwise untreatable by using any other publicly known technology.

Initially, I wanted to design a single device which would embody all of the underlying principles I observed during my previous years of research. However, it soon became obvious that it would be practically impossible for me to develop such “super”-electrotherapeutic device with limited funds I had at my disposal during that period. Instead, I chose to focus on the development of separate, more specialised electrotherapy devices, which could address some of the problems inherent in modern pharmacological medical treatments.

Cell Metabolism Rejuvenation

At first I turned my attention on the development of the electromedical device, which would be capable of producing specific, complex signals capable of stimulating cell metabolism rejuvenation by modifying electrochemical reactions in and around the living cells. My goal was primarily to stimulate ionic exchange processes of the Na+/K+ ionic pump (-ATPase), which would in turn increases cellular energy exchange processes and cellular transmembrane potential.

What I found at that point was that it is indeed possible to directly increase transmembrane potential by applying specifically synthesized electrical signals, thus directly affecting the cellular ionic exchange processes. In order to achieve that, in as simple way as possible, I decided to abandon somewhat complex and expensive technologies based on plasma antenna radiators (for example “Rife” technologies) which required more complex electrical design and relatively expensive parts. Finally, I decided to start development of the device based on application of electrical signal by direct electrodes contact with the body. Although beneficial effects on the body were immediate and obvious, most of the development time was spent on designing electronics circuitry, which would be safe enough to use in clinical environment while retaining all of the beneficial properties.

In 2008 I made the first entirely functional prototype for experimental purposes. At that point the device was tested in a small clinic in Netherlands, primarily for the treatment of pain. Based on the feedback I got, I designed two additionally improved developmental generations of the cell metabolism rejuvenation device and made it even more versatile. Interestingly enough, it also fast became obvious that this type of electromedical device appears to have most interesting beneficial side-effects. With the proper settings of the output signal and use of appropriate electronic circuitry, it appears that it is quite possible to induce programmed apoptosis in cells with low transmembrane potential (for example neoplastic cells), while at the same time ionic exchange processes are stimulated in the somewhat healthier cells (electrically speaking). Thus normalisation of their transmembrane potential and metabolic processes has been achieved.

Although the device was designed with capability of directly increasing transmembrane cell potential, it was still a bit of surprise to find that specific electrical signals are able to selectively induce cellular “suicide” of  neoplastic (low transmembrane potential) cells, while not harming the healthy cells.

Such way of direct manipulation of electrochemical processes in and around the living cells also opened the door of possible nerve conductivity restoration in damaged sensory and motoric nerves. It means that symptoms of various (poly)neuropathies were relatively quickly and obviously alleviated. Versatility of the device also allowed for modification of the device’s operational parameters in order to successfully treat both acute and chronic pain.

Further development and modifications of the device’s electrical design also allowed for the development of the quick and efficient treatment of gout. Symptoms like swelling and pain were immediately and obviously alleviated. Additionally, it was at that point established that somewhat modified methodology of gout treatment was rather efficient in the fast treatment of various types of oedema and tissue swellings.

Finally, once I perfected ways of transferring sufficient amount of electrical energy to the living cells without damaging them, I realised that the same principles would cause significant damage to prokaryotic cells (for example pathogen microorganisms), due to their somewhat different electrical properties when compared to eukaryotic cells.

The effects of selective killing of various types of prokaryotes with no apparent damage to the eukaryotic cells was no surprise to me but what did surprise me was that pretty much similar effects were observed with certain viral infections. For example, it was observed that virus count in the blood of the cat suffering from FIV infection (which is somewhat similar to HIV) dropped rapidly and significantly when the cat was treated with electrical signals produced by the device.

Although this type of electrotherapeutical methods appears rather promising in the treatments of several different types of medical conditions and diseases, it must be noted that this device is not panacea. It certainly has its limitations, and in case of some diseases it exhibited very limited effectiveness due to the different underlying mechanisms of their genesis.

Direct Modification of Body pH and Neutralisation of Excessive Levels of Free Radicals

Concurrently with the development of the cell metabolism rejuvenation device, I have also been developing entirely different type of electrotherapy device, which is able to very quickly and efficiently modify and regulate body pH in a direct way as well as to neutralise free radicals “in vivo”.

Due to my previous involvement with the commercial project of zeolite processing and enhancement for medicinal purposes, I was well aware of the significance of using strong antioxidants for modification (alkalisation in this case) of body pH and neutralisation of excessive levels of free radicals, which proved to be one of the major contributing factors in the successful treatment of some neoplastic and autoimmune diseases. At that point I already developed prototype for industrial processing and electrochemical enhancement of zeolite and similar micronized minerals, which measurably increases their electrochemical reactiveness several times. Although the resulting enhanced mineral products exhibit highest physically possible antioxidative properties, which are several times higher compared with commonly used antioxidants and conventionally micronized and activated zeolite, I was still not content with the achievable rate of neutralisation of excessive free radical levels.

I knew that in most severe cases of neoplastic and autoimmune diseases, fast and efficient alkalisation of the affected tissues and the entire body, as well as reduction of excessive levels of free radicals, are of paramount importance.

Although I found somewhat interesting references to historical, as well as somewhat more modern devices trying to achieve such effects “in vitro” in limited laboratory conditions, my initial experiments indicated that things are somewhat more complex if one is to achieve similar effects “in vivo” with complex multicellular organisms like humans and animals.

Initial experiments “in vitro” proved to me that the concept I had in mind was viable, however it required additional experimentation to determine what would be the most efficient way of achieving the same results “in vivo” in a reliable and safe way. For example, I found that when the amplitude of oscillation of the experimental device output was too low, the rate of free radicals neutralisation was virtually negligible. On the other hand, when the output amplitude of oscillation was too high, it sometimes lead to unpleasant side-effects of nervous system over-excitation, resulting in mild spatial disorientation and vertigo.

I finally overcome those initial obstacles during late 2008 and early 2009, which lead to the successful development of the first and rather unsophisticated prototype. Even in those early stages of development the results were very promising and they could be be reliably reproduced and verified by laboratory tests done by any medical biochemistry laboratory. With additional funding provided at that stage of development, the device evolved into two more advanced generations based on the data gathered during testing in the small clinic in Netherlands.

Once perfected, this device proved to be extremely efficient in very fast, controlled alkalisation of the entire organism and reduction of excessive levels of free radicals. In fact, this fast and non-invasive method of neutralisation of free radicals shows great potential in treatment of all medical conditions that are caused and indicated by high levels of free radicals in and around the affected tissues.

Aside for apparent applications as supplemental therapy in case of various neoplastic and autoimmune diseases, one of the more interesting fields of use are anti-ageing treatments and reduction of cellular damage caused by exposure to ionising radiations. Obvious sources of such ionising radiations are various X-ray, CT and PET scans which directly cause production of excessive levels of free-radicals in the organism.

Radioactive “hot particles” released by nuclear accidents are increasingly being absorbed by human and animal population. Each of those embedded radioactive “hot” particles invariably cause continuous increased production of free radicals, which often leads to the development of various degenerative and neoplastic diseases (for example thyroid cancer), so perhaps even more interesting application of this technology is for the purposes of reducing detrimental long-term effects of accumulated radioactive “hot” particles in the organism.

Current Research and Development of New Types of Electrotherapy Devices

Currently, I am working on entirely new technologies based on the knowledge and experience I gained on my work and experiments with previously described devices. Additionally, I had a recent opportunity to design, produce and perform experiments with historical replicas of Multiple-Wave Oscillator (MWO) and Rife “Beam Ray” plasma antenna radiator devices.

It appears that certain elements in all of those technologies have common denominators, which could be used to design and produce even more effective and capable electrotherapeutic devices. Plasma antenna radiator elements are of particular interest in this case, considering the possibility of modifying their radiation properties without necessity to physically change their components. Such new technologies should be capable of inducing additional beneficial bioactive effects, some of which are virtually impossible to achieve even with the last developmental generations of the existing electromedical devices.

Scroll to top
  Related Articles

Add a Comment